154 related articles for article (PubMed ID: 3403200)
1. Long-term effects of steroid and cytostatic treatment on the clinical course of idiopathic membranous glomerulonephritis (retrospective study).
Mohácsi G; Magori A; Sonkodi S
Int Urol Nephrol; 1988; 20(3):315-25. PubMed ID: 3403200
[TBL] [Abstract][Full Text] [Related]
2. Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis.
Orlowski T; Rancewicz Z; Lao M; Juskowa J; Klepacka J; Gradowska L; Morzycka-Michalik M; Glyda J
Klin Wochenschr; 1988 Oct; 66(20):1019-23. PubMed ID: 3148785
[TBL] [Abstract][Full Text] [Related]
3. Membranous nephropathy: response to steroids and immunosuppression.
Suki WN; Chavez A
Am J Nephrol; 1981; 1(1):11-6. PubMed ID: 7348534
[TBL] [Abstract][Full Text] [Related]
4. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
[TBL] [Abstract][Full Text] [Related]
5. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
Klinger M; Szewczyk Z
Przegl Lek; 1989; 46(12):816-21. PubMed ID: 2698488
[No Abstract] [Full Text] [Related]
6. Remission induced by chlorambucil in steroid-responsive, frequently relapsing nephrotic syndrome that relapsed after cyclophosphamide.
Bailey RR
N Z Med J; 1989 Jul; 102(872):379-81. PubMed ID: 2797556
[TBL] [Abstract][Full Text] [Related]
7. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
8. [Cytostatic treatment of the steroid-resistant nephrotic syndrome. (Long term study on 24 patients)].
Oechslen D; Kluthe R; Sarre H
Arch Klin Med; 1968; 215(2):150-60. PubMed ID: 5718136
[No Abstract] [Full Text] [Related]
9. Treatment of lupus nephritis.
Pollak VE
Adv Nephrol Necker Hosp; 1976; 6():137-61. PubMed ID: 828444
[No Abstract] [Full Text] [Related]
10. Cytostatic treatment of glomerular diseases. V. Treatment of glomerulonephritis with cyclophosphamide plus prednisone, azathioprine plus prednisone and cyclophosphamide as monotherapy. A comparative study. A report from a Copenhagen Study Group of Renal Diseases.
Brahm M; Balsløv JT; Brammer M; Brun C; Gerstoft J; Jørgensen HE; Kamper A; Larsen S; Lorenzen I; Thomsen AC
Acta Med Scand; 1988; 224(6):605-10. PubMed ID: 3061292
[TBL] [Abstract][Full Text] [Related]
11. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
12. Treatment of childhood prednisone-resistant nephrotic syndrome and focal segmental glomerulosclerosis with intravenous methylprednisolone and oral alkylating agents.
Griswold WR; Tune BM; Reznik VM; Vazquez M; Prime DJ; Brock P; Mendoza SA
Nephron; 1987; 46(1):73-7. PubMed ID: 3600915
[TBL] [Abstract][Full Text] [Related]
13. Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.
Schulman SL; Kaiser BA; Polinsky MS; Srinivasan R; Baluarte HJ
J Pediatr; 1988 Dec; 113(6):996-1001. PubMed ID: 3193322
[TBL] [Abstract][Full Text] [Related]
14. [Cyclophosphamide pulse therapy in patients with primary glomerulonephritis].
Rutkowski B; Wielgosz A; Manitius J; Bułło B; Kowalewska J; Tylicki L; Roszkiewicz A
Przegl Lek; 2000; 57(11):624-7. PubMed ID: 11293209
[TBL] [Abstract][Full Text] [Related]
15. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
[TBL] [Abstract][Full Text] [Related]
18. [Effect of immunosuppressive, anticoagulant and anti-inflammatory agents on experimental glomerulonephritis. VI. Encorton, immuran and cyclophosphamide].
Tyszkiewicz Z; Gawlik Z; Lewandowska T; Juska D
Patol Pol; 1984; 35(1):105-14. PubMed ID: 6493817
[No Abstract] [Full Text] [Related]
19. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
Grupe WE; Makker SP; Ingelfinger JR
N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
[TBL] [Abstract][Full Text] [Related]
20. ACTH and azathioprine: antiproteinuric and lipid-lowering effect in the course of idiopathic membranous glomerulonephritis.
Gigante A; Rosato E; Liberatori M; Gasperini ML; Giannakakis K; Barbano B; Cianci R; Salsano F; Amoroso A
J Biol Regul Homeost Agents; 2012; 26(1):135-8. PubMed ID: 22475105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
